Featured
Trastuzumab Course Length in Breast Cancer
The Importance of Supporting New Nurses
Join Us at the ONA Navigation ...
Hormone Therapy for Breast Cancer
FMT in Managing Immunotherapy-Associated Colitis
Let Us Answer Your Oncology Question
Chronic Lymphocytic Leukemia: A Nursing Perspective
Features
Regular Physical Activity Improves Survival for Cancer Patients
A review of DBBR data demonstrated that regular recreational physical activity may reduce the risk of all-cause and cancer-specific mortality in persons who are habitually active as a lifestyle as well as those who adopt regular exercise as a lifestyle after diagnosis.
Mentoring 101: A Call to Support New Nurses
Nurses need to rethink their attitude toward those who are new to the profession, lead with compassion, and share their knowledge gained through experience.
Advisor Forum
Counseling on the Dangers of Vaping
How can nurses caring for smokers counsel patients on quitting smoking when many are using vaping as an alternative to cigarettes?
Adjusting Etoposide Dose When Used With Prezcobix
Do you have any resources that give specific guidelines or even anecdotal sources on how to adjust etoposide dose in a patient taking Prezcobix?
Assessment Tool for Immunotherapy Side Effects
My patient is receiving immunotherapy. What is the best tool for assessing side effects?
Fact Sheets
Hormone Therapy for Breast Cancer (Fact Sheet)
This fact sheet reviews the use of hormone therapy in breast cancer therapy and possible side effects of treatment.
Physical Activity and Cancer (Fact Sheet)
This fact sheet examines the role of physical activity and exercise in cancer prevention and cancer survivorship.
Trial Tracker
Challenges Faced by Oncology Nurses
Digital Issue
Editorial Board
Eucharia Borden, MSW, LCSW, OSW-C
Ann J. Brady, MSN, RN-BC, CHPN
Jiajoyce R. Conway, DNP, CRNP, AOCNP
Marianne Davies, DNP, ACNP, AOCNP
Frank dela Rama, RN, MS, AOCNS
Donald R. Fleming, MD
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
Kara M.L. Yannotti, MMH, BSN, RN, CCRP
.
Sign Up for Free e-newsletters
ONA Articles
- Hormone Therapy for Breast Cancer (Fact Sheet)
- Cancer Treatment and Research: What Lies Ahead in 2019
- 9-Week Trastuzumab Course Not Noninferior to Standard Course for HER2+ Breast Cancer, But Does Offer a Benefit
- Imported Doxorubicin Similar to US FDA-Approved Brand in Relapsed/Refractory Ovarian Cancer
- Psychoeducational Intervention of Little Benefit in Breast Cancer
- Brain Exercise Program Eases Chemobrain in Breast Cancer Survivors
- Counseling on the Dangers of Vaping
- Radical Prostatectomy vs Active Surveillance: Results of Nearly 3 Decades of Follow-up
- Potential of Fecal Microbiota Transplantation in Managing Immunotherapy-Associated Colitis
- Hormone Therapy for Breast Cancer (Fact Sheet)
- ASCO Convenes Panel to Address Handling of Hazardous Drugs
- Cancer Death Rate in U.S. Decreased Continuously From 1991 to 2016
- Cancer Treatment and Research: What Lies Ahead in 2019
- Medical Marketing Has Increased in Past 20 Years
- Regular Physical Activity — Even Initiated Postdiagnosis — Improves Survival for Cancer Patients
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |